WordNet

Finnish physician who first described vascular hemophilia (1870-1949) (同)von_Willebrand, E. A. von Willebrand, Erik von Willebrand, Erik Adolf von Willebrand

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2016/01/06 23:27:11」(JST)

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. von Willebrand病の臨床症状および診断 clinical presentation and diagnosis of von willebrand disease
2. von Willebrand病の治療 treatment of von willebrand disease
3. von Willebrand病の分類および病態生理 classification and pathophysiology of von willebrand disease
4. 後天性フォン・ヴィレブランド症候群 acquired von willebrand syndrome
5. von Willebrand因子の生物学および正常機能 biology and normal function of von willebrand factor

A common founder mutation p.P2063S in exon 36 of VWF in 11 unrelated Indian von Willebrand disease (VWD) families.

Kasatkar P, Ghosh K, Shetty S.SourceNational Institute of Immunohematology (ICMR), KEM Hospital, Parel, Mumbai, 400 012, India.
Annals of hematology.Ann Hematol.2013 Aug;92(8):1147-8. doi: 10.1007/s00277-013-1680-x. Epub 2013 Jan 27.
PMID 23354996

Treatment of salivary gland hypofunction by transplantation with dental pulp cells.

Yamamura Y, Yamada H, Sakurai T, Ide F, Inoue H, Muramatsu T, Mishima K, Hamada Y, Saito I.SourceDepartment of Oral and Maxillofacial Surgery, School of Dental Medicine, Tsurumi University, 2-1-3 Tsurumi, Tsurumi-ku, Yokohama 230-8501, Japan.
Archives of oral biology.Arch Oral Biol.2013 Aug;58(8):935-42. doi: 10.1016/j.archoralbio.2013.02.015. Epub 2013 Apr 6.
OBJECTIVE: This study aimed to establish a mouse model in which dental pulp cells (DPCs) could be used as a cell source for the treatment of salivary gland hypofunction.DESIGN: DPCs were isolated from green fluorescent protein (GFP)-expressing mice and were differentiated into dental pulp endothelia
PMID 23570866

Late-phase inflammatory response as a feature of in-stent restenosis after drug-eluting stent implantation.

Yoneda S, Abe S, Kanaya T, Oda K, Nishino S, Kageyama M, Taguchi I, Masawa N, Inoue T.SourceDepartments of aCardiovascular Medicine bPathology, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan.
Coronary artery disease.Coron Artery Dis.2013 Aug;24(5):368-73. doi: 10.1097/MCA.0b013e32836222ec.
OBJECTIVES: The aim of this study was to compare pathological features among in-stent restenosis lesions after drug-eluting stent (DES) placement, those after bare metal stent (BMS) placement, and de-novo atherosclerotic lesions.BACKGROUND: Restenosis after stenting is an over-reaction of the wound-
PMID 23744617